A decreasing trend of malignancy risk has been noted over this 5-year time period, with the greatest standardized incidence ratio (SIR) during the first year after the diagnosis of DM.
← all excerpts
Dermatomyositis and malignancy: should all patients with dermatomyositis undergo malignancy screening?
1
—
—